463 related articles for article (PubMed ID: 31840869)
1. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats.
Renko JM; Mahato AK; Visnapuu T; Valkonen K; Karelson M; Voutilainen MH; Saarma M; Tuominen RK; Sidorova YA
J Parkinsons Dis; 2021; 11(3):1023-1046. PubMed ID: 34024778
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling.
Kasanga EA; Han Y; Navarrete W; McManus R; Shifflet MK; Parry C; Barahona A; Manfredsson FP; Nejtek VA; Richardson JR; Salvatore MF
Exp Neurol; 2023 Aug; 366():114435. PubMed ID: 37178997
[TBL] [Abstract][Full Text] [Related]
4. GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson's Disease.
Renko JM; Voutilainen MH; Visnapuu T; Sidorova YA; Saarma M; Tuominen RK
Front Neurol Neurosci Res; 2020 Nov; 1():100004. PubMed ID: 33479704
[TBL] [Abstract][Full Text] [Related]
5. ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways.
Araujo DM; Hilt DC; Miller PJ; Wen D; Jiao S; Lapchak PA
Neuroscience; 1997 Sep; 80(1):9-16. PubMed ID: 9252216
[TBL] [Abstract][Full Text] [Related]
6. 6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo.
Gavin AM; Walsh S; Wyatt S; O'Keeffe GW; Sullivan AM
Neurosci Lett; 2014 Feb; 561():176-81. PubMed ID: 24373993
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
8. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
9. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
11. Dopamine neuron stimulating actions of a GDNF propeptide.
Bradley LH; Fuqua J; Richardson A; Turchan-Cholewo J; Ai Y; Kelps KA; Glass JD; He X; Zhang Z; Grondin R; Littrell OM; Huettl P; Pomerleau F; Gash DM; Gerhardt GA
PLoS One; 2010 Mar; 5(3):e9752. PubMed ID: 20305789
[TBL] [Abstract][Full Text] [Related]
12. Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.
Drinkut A; Tillack K; Meka DP; Schulz JB; Kügler S; Kramer ER
Cell Death Dis; 2016 Sep; 7(9):e2359. PubMed ID: 27607574
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
14. Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system.
Kramer ER; Aron L; Ramakers GM; Seitz S; Zhuang X; Beyer K; Smidt MP; Klein R
PLoS Biol; 2007 Mar; 5(3):e39. PubMed ID: 17298183
[TBL] [Abstract][Full Text] [Related]
15. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of glial cell-derived neurotrophic factor loaded collagen scaffolds in ex vivo organotypic brain slice Parkinson's disease models.
Ucar B; Humpel C
Brain Res Bull; 2019 Jul; 149():86-95. PubMed ID: 31004735
[TBL] [Abstract][Full Text] [Related]
17. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
18. GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function.
Kumar A; Kopra J; Varendi K; Porokuokka LL; Panhelainen A; Kuure S; Marshall P; Karalija N; Härma MA; Vilenius C; Lilleväli K; Tekko T; Mijatovic J; Pulkkinen N; Jakobson M; Jakobson M; Ola R; Palm E; Lindahl M; Strömberg I; Võikar V; Piepponen TP; Saarma M; Andressoo JO
PLoS Genet; 2015 Dec; 11(12):e1005710. PubMed ID: 26681446
[TBL] [Abstract][Full Text] [Related]
19. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
20. GFR-α1 Expression in Substantia Nigra Increases Bilaterally Following Unilateral Striatal GDNF in Aged Rats and Attenuates Nigral Tyrosine Hydroxylase Loss Following 6-OHDA Nigrostriatal Lesion.
Kasanga EA; Owens CL; Cantu MA; Richard AD; Davis RW; McDivitt LM; Blancher B; Pruett BS; Tan C; Gajewski A; Manfredsson FP; Nejtek VA; Salvatore MF
ACS Chem Neurosci; 2019 Oct; 10(10):4237-4249. PubMed ID: 31538765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
